Priscila Schilrreff

760 total citations · 1 hit paper
17 papers, 583 citations indexed

About

Priscila Schilrreff is a scholar working on Pharmaceutical Science, Molecular Biology and Immunology. According to data from OpenAlex, Priscila Schilrreff has authored 17 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Priscila Schilrreff's work include Advancements in Transdermal Drug Delivery (7 papers), Dendrimers and Hyperbranched Polymers (4 papers) and RNA Interference and Gene Delivery (4 papers). Priscila Schilrreff is often cited by papers focused on Advancements in Transdermal Drug Delivery (7 papers), Dendrimers and Hyperbranched Polymers (4 papers) and RNA Interference and Gene Delivery (4 papers). Priscila Schilrreff collaborates with scholars based in Argentina, Germany and Brazil. Priscila Schilrreff's co-authors include Ulrike Alexiev, María José Morilla, Eder Lilia Romero, Ana Paula Perez, María Julia Altube, Susana Zacchino, Fabiana S. Celes, Camila I. de Oliveira, Cecilia Mundiña‐Weilenmann and Marcelo Alexandre de Farias and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Priscila Schilrreff

16 papers receiving 570 citations

Hit Papers

Chronic Inflammation in Non-Healing Skin Wounds and Promi... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priscila Schilrreff Argentina 13 190 135 96 81 77 17 583
Keng Wooi Ng United Kingdom 14 231 1.2× 241 1.8× 33 0.3× 64 0.8× 51 0.7× 27 651
Valamla Bhavana India 16 160 0.8× 216 1.6× 34 0.4× 226 2.8× 46 0.6× 27 712
Leslie Gunther United States 8 157 0.8× 96 0.7× 175 1.8× 150 1.9× 75 1.0× 10 799
Anca Maria Juncan Romania 9 171 0.9× 67 0.5× 41 0.4× 157 1.9× 21 0.3× 25 651
Jorge Montanari Argentina 17 203 1.1× 165 1.2× 17 0.2× 94 1.2× 57 0.7× 35 622
Zaida Urbán‐Morlán Mexico 10 85 0.4× 191 1.4× 31 0.3× 93 1.1× 33 0.4× 12 480
Stefan Hönzke Germany 12 104 0.5× 264 2.0× 20 0.2× 101 1.2× 53 0.7× 14 591
Nikita Devnarain South Africa 15 230 1.2× 149 1.1× 47 0.5× 157 1.9× 27 0.4× 31 702
Delia Mihaela Raţă Romania 14 153 0.8× 143 1.1× 44 0.5× 313 3.9× 29 0.4× 35 605
Anca Niculina Cadinoiu Romania 15 174 0.9× 203 1.5× 36 0.4× 338 4.2× 32 0.4× 36 660

Countries citing papers authored by Priscila Schilrreff

Since Specialization
Citations

This map shows the geographic impact of Priscila Schilrreff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscila Schilrreff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscila Schilrreff more than expected).

Fields of papers citing papers by Priscila Schilrreff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscila Schilrreff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscila Schilrreff. The network helps show where Priscila Schilrreff may publish in the future.

Co-authorship network of co-authors of Priscila Schilrreff

This figure shows the co-authorship network connecting the top 25 collaborators of Priscila Schilrreff. A scholar is included among the top collaborators of Priscila Schilrreff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscila Schilrreff. Priscila Schilrreff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Butassi, Estefanía, et al.. (2025). Biocompatibility, anti-inflammatory, wound healing, and antifungal activity of macrophage targeted-bacterioruberin-vitamin D3 loaded nanoparticles. Journal of Drug Delivery Science and Technology. 105. 106661–106661.
2.
Salvay, Andrés G., et al.. (2024). Activity of hydrogel-vitamin D3 /bacterioruberin nanoparticles on imiquimod-induced fibroblasts-keratinocytes spheroids. Journal of Drug Delivery Science and Technology. 97. 105738–105738. 3 indexed citations
3.
Schilrreff, Priscila & Ulrike Alexiev. (2022). Chronic Inflammation in Non-Healing Skin Wounds and Promising Natural Bioactive Compounds Treatment. International Journal of Molecular Sciences. 23(9). 4928–4928. 171 indexed citations breakdown →
4.
Barbosa, Leandro R.S., et al.. (2022). Enhancing the anti-psoriatic activity of vitamin D3 employing nanostructured archaeolipid carriers. Journal of Drug Delivery Science and Technology. 73. 103455–103455. 13 indexed citations
5.
Schilrreff, Priscila, et al.. (2020). Bacterioruberin from Haloarchaea plus dexamethasone in ultra-small macrophage-targeted nanoparticles as potential intestinal repairing agent. Colloids and Surfaces B Biointerfaces. 191. 110961–110961. 27 indexed citations
6.
Schilrreff, Priscila, et al.. (2019). Superoxide dismutase in nanoarchaeosomes for targeted delivery to inflammatory macrophages. Colloids and Surfaces B Biointerfaces. 179. 479–487. 25 indexed citations
7.
Volz, Pierre, Priscila Schilrreff, Robert Brodwolf, et al.. (2017). Pitfalls in using fluorescence tagging of nanomaterials: tecto‐dendrimers in skin tissue as investigated by Cluster‐FLIM. Annals of the New York Academy of Sciences. 1405(1). 202–214. 17 indexed citations
8.
Murta, Verónica, et al.. (2017). G5G2.5 core‐shell tecto‐dendrimer specifically targets reactive glia in brain ischemia. Journal of Neurochemistry. 144(6). 748–760. 14 indexed citations
9.
Arnal, Laura, Mónica Vermeulen, Ana Paula Perez, et al.. (2016). Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens. PLoS ONE. 11(3). e0150185–e0150185. 29 indexed citations
10.
Perez, Ana Paula, María Julia Altube, Priscila Schilrreff, et al.. (2015). Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids and Surfaces B Biointerfaces. 139. 190–198. 121 indexed citations
11.
Zoschke, Christian, et al.. (2015). Dendritic Nanoparticles for Cutaneous Drug Delivery - Testing in Human Skin and Reconstructed Human Skin. Current Pharmaceutical Design. 21(20). 2784–2800. 15 indexed citations
12.
Romero, Eder Lilia, Ana Paula Perez, Priscila Schilrreff, et al.. (2014). Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes. International Journal of Nanomedicine. 9. 3335–3335. 21 indexed citations
13.
Schilrreff, Priscila, et al.. (2014). Enhanced antimelanoma activity of methotrexate and zoledronic acid within polymeric sandwiches. Colloids and Surfaces B Biointerfaces. 122. 19–29. 10 indexed citations
14.
Schilrreff, Priscila, et al.. (2012). Ultradeformable archaeosomes as new topical adjuvants. Nanomedicine Nanotechnology Biology and Medicine. 8(8). 1319–1328. 50 indexed citations
15.
Schilrreff, Priscila, et al.. (2012). The Intervention of Nanotechnology Against Epithelial Fungal Diseases. Journal of Biomaterials and Tissue Engineering. 3(1). 70–88. 11 indexed citations
16.
Morilla, María José, Priscila Schilrreff, Cecilia Mundiña‐Weilenmann, & Eder Lilia Romero. (2012). Selective cytotoxicity of PAMAM G5 core–PAMAM G2.5 shell tecto-dendrimers on melanoma cells. International Journal of Nanomedicine. 7. 4121–4121. 35 indexed citations
17.
Prieto, María Jimena, et al.. (2008). Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine. International Journal of Pharmaceutics. 360(1-2). 204–212. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026